Search

everythinglearnresearchcommunity

for

Search:↓

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

TRH stimulates human hair growth and extends the hair growth phase.

DORN1 receptor affects eATP-induced stomatal changes but not eADP in Arabidopsis thaliana.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

A specific RNA helps increase the growth of skin cells in Liaoning cashmere goats by working with a protein to boost a growth-related gene.

Retinoic acid production and signaling in hair follicles are regulated by location and timing, affecting hair growth and cycling.

The 3D structure of a key hair protein was modeled, revealing specific helical structures and stabilization features.

All Indian dromedary camel breeds have the same KRTAP7 gene affecting hair quality.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Blocking LFA-1 prevents hair loss in mice.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Lack of cystatin M/E causes thin hair and dry skin.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Mechanical stress causes ligament thickening through WISP-1 and Hedgehog signaling.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

CRH causes hair loss by reducing cell survival in hair follicles.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.